MedPath

Evaluation of in vitro assays (lymphocyte proliferation assays, cytokine production assays and/or T spot TBtm and/or Quantiferon-TB Gold) during follow-up of individuals with recent Mantoux skin test conversion, or (latent or clinically active) Tuberculosis.

Recruiting
Conditions
prevention
Tuberculosis
10021460
Registration Number
NL-OMON31206
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Age at least 18 Years at time of entry into the study.
Positive TST result during a contact investigation, or being (have been) treated for latent or active tuberculosis.
Written informed consent.

Exclusion Criteria

nvt

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>nvt</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>T Spot TB and Quantiferon-TB Gold.</p><br>
© Copyright 2025. All Rights Reserved by MedPath